ヒト酸性線維芽細胞成長因子（aFGF）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Human Acidic Fibroblast Growth Factor (aFGF) Market Insights, Forecast to 2028

• レポートコード：QY2207E10372 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のヒト酸性線維芽細胞成長因子（aFGF）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒト酸性線維芽細胞成長因子（aFGF）の世界市場のxxx％を占める「液体」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「循環器疾患」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のヒト酸性線維芽細胞成長因子（aFGF）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのヒト酸性線維芽細胞成長因子（aFGF）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのヒト酸性線維芽細胞成長因子（aFGF）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ヒト酸性線維芽細胞成長因子（aFGF）のグローバル主要メーカーには、ProSpec、Thermo Fisher Scientific、Peprotech、Essex Bio-Technology、Lonza、Shanghai Tenry Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ヒト酸性線維芽細胞成長因子（aFGF）市場は、種類と用途によって区分されます。世界のヒト酸性線維芽細胞成長因子（aFGF）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 液体、乾燥粉末 【用途別セグメント】 循環器疾患、皮膚病、糖尿病、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ヒト酸性線維芽細胞成長因子（aFGF）製品概要 - 種類別市場（液体、乾燥粉末） - 用途別市場（循環器疾患、皮膚病、糖尿病、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のヒト酸性線維芽細胞成長因子（aFGF）販売量予測2017-2028 - 世界のヒト酸性線維芽細胞成長因子（aFGF）売上予測2017-2028 - ヒト酸性線維芽細胞成長因子（aFGF）の地域別販売量 - ヒト酸性線維芽細胞成長因子（aFGF）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ヒト酸性線維芽細胞成長因子（aFGF）販売量 - 主要メーカー別ヒト酸性線維芽細胞成長因子（aFGF）売上 - 主要メーカー別ヒト酸性線維芽細胞成長因子（aFGF）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（液体、乾燥粉末） - ヒト酸性線維芽細胞成長因子（aFGF）の種類別販売量 - ヒト酸性線維芽細胞成長因子（aFGF）の種類別売上 - ヒト酸性線維芽細胞成長因子（aFGF）の種類別価格 ・用途別市場規模（循環器疾患、皮膚病、糖尿病、その他） - ヒト酸性線維芽細胞成長因子（aFGF）の用途別販売量 - ヒト酸性線維芽細胞成長因子（aFGF）の用途別売上 - ヒト酸性線維芽細胞成長因子（aFGF）の用途別価格 ・北米市場 - 北米のヒト酸性線維芽細胞成長因子（aFGF）市場規模（種類別、用途別） - 主要国別のヒト酸性線維芽細胞成長因子（aFGF）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのヒト酸性線維芽細胞成長因子（aFGF）市場規模（種類別、用途別） - 主要国別のヒト酸性線維芽細胞成長因子（aFGF）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のヒト酸性線維芽細胞成長因子（aFGF）市場規模（種類別、用途別） - 主要国別のヒト酸性線維芽細胞成長因子（aFGF）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のヒト酸性線維芽細胞成長因子（aFGF）市場規模（種類別、用途別） - 主要国別のヒト酸性線維芽細胞成長因子（aFGF）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのヒト酸性線維芽細胞成長因子（aFGF）市場規模（種類別、用途別） - 主要国別のヒト酸性線維芽細胞成長因子（aFGF）市場規模（トルコ、サウジアラビア） ・企業情報 ProSpec、Thermo Fisher Scientific、Peprotech、Essex Bio-Technology、Lonza、Shanghai Tenry Pharmaceutical ・産業チェーン及び販売チャネル分析 - ヒト酸性線維芽細胞成長因子（aFGF）の産業チェーン分析 - ヒト酸性線維芽細胞成長因子（aFGF）の原材料 - ヒト酸性線維芽細胞成長因子（aFGF）の生産プロセス - ヒト酸性線維芽細胞成長因子（aFGF）の販売及びマーケティング - ヒト酸性線維芽細胞成長因子（aFGF）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ヒト酸性線維芽細胞成長因子（aFGF）の産業動向 - ヒト酸性線維芽細胞成長因子（aFGF）のマーケットドライバー - ヒト酸性線維芽細胞成長因子（aFGF）の課題 - ヒト酸性線維芽細胞成長因子（aFGF）の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Human Acidic Fibroblast Growth Factor (aFGF) Market
Due to the COVID-19 pandemic, the global Human Acidic Fibroblast Growth Factor (aFGF) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Liquid Type accounting for % of the Human Acidic Fibroblast Growth Factor (aFGF) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cardiovascular Diseases segment is altered to an % CAGR throughout this forecast period.
China Human Acidic Fibroblast Growth Factor (aFGF) market size is valued at US$ million in 2021, while the US and Europe Human Acidic Fibroblast Growth Factor (aFGF) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Human Acidic Fibroblast Growth Factor (aFGF) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Human Acidic Fibroblast Growth Factor (aFGF) include ProSpec, Thermo Fisher Scientific, Peprotech, Essex Bio-Technology, Lonza and Shanghai Tenry Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Human Acidic Fibroblast Growth Factor (aFGF) Scope and Segment
Human Acidic Fibroblast Growth Factor (aFGF) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Acidic Fibroblast Growth Factor (aFGF) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Liquid Type
Dry Powder
Segment by Application
Cardiovascular Diseases
Skin Disease
Diabetes
Other
By Company
ProSpec
Thermo Fisher Scientific
Peprotech
Essex Bio-Technology
Lonza
Shanghai Tenry Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Human Acidic Fibroblast Growth Factor (aFGF) Product Introduction
1.2 Market by Type
1.2.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid Type
1.2.3 Dry Powder
1.3 Market by Application
1.3.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cardiovascular Diseases
1.3.3 Skin Disease
1.3.4 Diabetes
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Estimates and Forecasts 2017-2028
2.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region
2.4.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region (2017-2022)
2.4.2 Global Sales Human Acidic Fibroblast Growth Factor (aFGF) by Region (2023-2028)
2.5 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region
2.5.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2017-2022)
2.5.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Manufacturers
3.1.1 Global Top Human Acidic Fibroblast Growth Factor (aFGF) Manufacturers by Sales (2017-2022)
3.1.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Acidic Fibroblast Growth Factor (aFGF) in 2021
3.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Manufacturers
3.2.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Acidic Fibroblast Growth Factor (aFGF) Revenue in 2021
3.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type
4.1.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Historical Sales by Type (2017-2022)
4.1.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
4.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type
4.2.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Historical Revenue by Type (2017-2022)
4.2.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
4.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Price by Type
4.3.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Price by Type (2017-2022)
4.3.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application
5.1.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Historical Sales by Application (2017-2022)
5.1.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
5.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application
5.2.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Historical Revenue by Application (2017-2022)
5.2.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
5.3 Global Human Acidic Fibroblast Growth Factor (aFGF) Price by Application
5.3.1 Global Human Acidic Fibroblast Growth Factor (aFGF) Price by Application (2017-2022)
5.3.2 Global Human Acidic Fibroblast Growth Factor (aFGF) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Type
6.1.1 North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2028)
6.1.2 North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2028)
6.2 North America Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Application
6.2.1 North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2028)
6.2.2 North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2028)
6.3 North America Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Country
6.3.1 North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2028)
6.3.2 North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Type
7.1.1 Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2028)
7.1.2 Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2028)
7.2 Europe Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Application
7.2.1 Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2028)
7.2.2 Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2028)
7.3 Europe Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Country
7.3.1 Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2028)
7.3.2 Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Type
8.1.1 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2028)
8.2 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Application
8.2.1 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2028)
8.3 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Region
8.3.1 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Type
9.1.1 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2028)
9.1.2 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2028)
9.2 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Application
9.2.1 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2028)
9.2.2 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2028)
9.3 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Country
9.3.1 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2028)
9.3.2 Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Type
10.1.1 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Application
10.2.1 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Market Size by Country
10.3.1 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ProSpec
11.1.1 ProSpec Corporation Information
11.1.2 ProSpec Overview
11.1.3 ProSpec Human Acidic Fibroblast Growth Factor (aFGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ProSpec Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ProSpec Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific Human Acidic Fibroblast Growth Factor (aFGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Fisher Scientific Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Peprotech
11.3.1 Peprotech Corporation Information
11.3.2 Peprotech Overview
11.3.3 Peprotech Human Acidic Fibroblast Growth Factor (aFGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Peprotech Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Peprotech Recent Developments
11.4 Essex Bio-Technology
11.4.1 Essex Bio-Technology Corporation Information
11.4.2 Essex Bio-Technology Overview
11.4.3 Essex Bio-Technology Human Acidic Fibroblast Growth Factor (aFGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Essex Bio-Technology Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Essex Bio-Technology Recent Developments
11.5 Lonza
11.5.1 Lonza Corporation Information
11.5.2 Lonza Overview
11.5.3 Lonza Human Acidic Fibroblast Growth Factor (aFGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Lonza Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lonza Recent Developments
11.6 Shanghai Tenry Pharmaceutical
11.6.1 Shanghai Tenry Pharmaceutical Corporation Information
11.6.2 Shanghai Tenry Pharmaceutical Overview
11.6.3 Shanghai Tenry Pharmaceutical Human Acidic Fibroblast Growth Factor (aFGF) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shanghai Tenry Pharmaceutical Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shanghai Tenry Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Acidic Fibroblast Growth Factor (aFGF) Industry Chain Analysis
12.2 Human Acidic Fibroblast Growth Factor (aFGF) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Acidic Fibroblast Growth Factor (aFGF) Production Mode & Process
12.4 Human Acidic Fibroblast Growth Factor (aFGF) Sales and Marketing
12.4.1 Human Acidic Fibroblast Growth Factor (aFGF) Sales Channels
12.4.2 Human Acidic Fibroblast Growth Factor (aFGF) Distributors
12.5 Human Acidic Fibroblast Growth Factor (aFGF) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Acidic Fibroblast Growth Factor (aFGF) Industry Trends
13.2 Human Acidic Fibroblast Growth Factor (aFGF) Market Drivers
13.3 Human Acidic Fibroblast Growth Factor (aFGF) Market Challenges
13.4 Human Acidic Fibroblast Growth Factor (aFGF) Market Restraints
14 Key Findings in The Global Human Acidic Fibroblast Growth Factor (aFGF) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Human Acidic Fibroblast Growth Factor (aFGF) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Liquid Type
Table 3. Major Manufacturers of Dry Powder
Table 4. Global Human Acidic Fibroblast Growth Factor (aFGF) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region (2017-2022) & (K Units)
Table 7. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Region (2017-2022)
Table 8. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region (2023-2028) & (K Units)
Table 9. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Region (2023-2028)
Table 10. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Region (2017-2022)
Table 12. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Region (2023-2028)
Table 14. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Manufacturers (2017-2022)
Table 18. Human Acidic Fibroblast Growth Factor (aFGF) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Human Acidic Fibroblast Growth Factor (aFGF) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Acidic Fibroblast Growth Factor (aFGF) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Acidic Fibroblast Growth Factor (aFGF) as of 2021)
Table 21. Human Acidic Fibroblast Growth Factor (aFGF) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Acidic Fibroblast Growth Factor (aFGF) Product Offered
Table 23. Date of Manufacturers Enter into Human Acidic Fibroblast Growth Factor (aFGF) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2022) & (K Units)
Table 26. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2023-2028) & (K Units)
Table 27. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Type (2017-2022)
Table 28. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Type (2023-2028)
Table 29. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Type (2017-2022)
Table 32. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Type (2023-2028)
Table 33. Human Acidic Fibroblast Growth Factor (aFGF) Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Human Acidic Fibroblast Growth Factor (aFGF) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2022) & (K Units)
Table 36. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2023-2028) & (K Units)
Table 37. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Application (2017-2022)
Table 38. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Application (2023-2028)
Table 39. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Application (2017-2022)
Table 42. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Application (2023-2028)
Table 43. Human Acidic Fibroblast Growth Factor (aFGF) Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Human Acidic Fibroblast Growth Factor (aFGF) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2022) & (K Units)
Table 46. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2023-2028) & (K Units)
Table 47. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2022) & (K Units)
Table 50. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2023-2028) & (K Units)
Table 51. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2022) & (K Units)
Table 54. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2023-2028) & (K Units)
Table 55. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2022) & (K Units)
Table 58. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2023-2028) & (K Units)
Table 59. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2022) & (K Units)
Table 62. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2023-2028) & (K Units)
Table 63. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2022) & (K Units)
Table 66. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2023-2028) & (K Units)
Table 67. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue by Country (2023-2028) & (US$ Million)
Table 105. ProSpec Corporation Information
Table 106. ProSpec Description and Major Businesses
Table 107. ProSpec Human Acidic Fibroblast Growth Factor (aFGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. ProSpec Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. ProSpec Recent Developments
Table 110. Thermo Fisher Scientific Corporation Information
Table 111. Thermo Fisher Scientific Description and Major Businesses
Table 112. Thermo Fisher Scientific Human Acidic Fibroblast Growth Factor (aFGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Thermo Fisher Scientific Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Thermo Fisher Scientific Recent Developments
Table 115. Peprotech Corporation Information
Table 116. Peprotech Description and Major Businesses
Table 117. Peprotech Human Acidic Fibroblast Growth Factor (aFGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Peprotech Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Peprotech Recent Developments
Table 120. Essex Bio-Technology Corporation Information
Table 121. Essex Bio-Technology Description and Major Businesses
Table 122. Essex Bio-Technology Human Acidic Fibroblast Growth Factor (aFGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Essex Bio-Technology Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Essex Bio-Technology Recent Developments
Table 125. Lonza Corporation Information
Table 126. Lonza Description and Major Businesses
Table 127. Lonza Human Acidic Fibroblast Growth Factor (aFGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Lonza Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Lonza Recent Developments
Table 130. Shanghai Tenry Pharmaceutical Corporation Information
Table 131. Shanghai Tenry Pharmaceutical Description and Major Businesses
Table 132. Shanghai Tenry Pharmaceutical Human Acidic Fibroblast Growth Factor (aFGF) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Shanghai Tenry Pharmaceutical Human Acidic Fibroblast Growth Factor (aFGF) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Shanghai Tenry Pharmaceutical Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Acidic Fibroblast Growth Factor (aFGF) Distributors List
Table 138. Human Acidic Fibroblast Growth Factor (aFGF) Customers List
Table 139. Human Acidic Fibroblast Growth Factor (aFGF) Market Trends
Table 140. Human Acidic Fibroblast Growth Factor (aFGF) Market Drivers
Table 141. Human Acidic Fibroblast Growth Factor (aFGF) Market Challenges
Table 142. Human Acidic Fibroblast Growth Factor (aFGF) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Acidic Fibroblast Growth Factor (aFGF) Product Picture
Figure 3. Global Human Acidic Fibroblast Growth Factor (aFGF) Market Share by Type in 2021 & 2028
Figure 3. Liquid Type Product Picture
Figure 4. Dry Powder Product Picture
Figure 5. Global Human Acidic Fibroblast Growth Factor (aFGF) Market Share by Application in 2021 & 2028
Figure 6. Cardiovascular Diseases
Figure 7. Skin Disease
Figure 8. Diabetes
Figure 9. Other
Figure 10. Human Acidic Fibroblast Growth Factor (aFGF) Report Years Considered
Figure 11. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales 2017-2028 (K Units)
Figure 12. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Region (2017-2022)
Figure 16. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Region (2023-2028)
Figure 17. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales YoY (2017-2028) & (K Units)
Figure 18. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Human Acidic Fibroblast Growth Factor (aFGF) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Human Acidic Fibroblast Growth Factor (aFGF) in the World: Market Share by Human Acidic Fibroblast Growth Factor (aFGF) Revenue in 2021
Figure 29. Global Human Acidic Fibroblast Growth Factor (aFGF) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
Figure 31. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
Figure 32. Global Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
Figure 33. Global Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
Figure 34. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
Figure 35. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
Figure 36. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
Figure 37. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
Figure 38. North America Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Country (2017-2028)
Figure 39. North America Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Country (2017-2028)
Figure 40. United States Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
Figure 43. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
Figure 45. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Country (2017-2028)
Figure 47. Europe Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Country (2017-2028)
Figure 48. Germany Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 49. France Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Region (2017-2028)
Figure 59. China Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 62. India Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
Figure 69. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
Figure 71. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Country (2017-2028)
Figure 73. Latin America Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Country (2017-2028)
Figure 74. Mexico Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Human Acidic Fibroblast Growth Factor (aFGF) Revenue Share by Country (2017-2028)
Figure 83. Turkey Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Human Acidic Fibroblast Growth Factor (aFGF) Revenue (2017-2028) & (US$ Million)
Figure 86. Human Acidic Fibroblast Growth Factor (aFGF) Value Chain
Figure 87. Human Acidic Fibroblast Growth Factor (aFGF) Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---